Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:small_molecule
gptkb:drug |
| gptkbp:alternativeName |
PN-235
PTG-200 |
| gptkbp:ATCCode |
not assigned
|
| gptkbp:clinicalTrialPhase |
Phase 3
|
| gptkbp:developedBy |
gptkb:Janssen_Pharmaceuticals
gptkb:Protagonist_Therapeutics |
| gptkbp:indication |
psoriasis
|
| gptkbp:mechanismOfAction |
interleukin-23 receptor antagonist
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:status |
investigational
|
| gptkbp:target |
IL-23 receptor
|
| gptkbp:bfsParent |
gptkb:Protagonist_Therapeutics
|
| gptkbp:bfsLayer |
8
|
| http://www.w3.org/2000/01/rdf-schema#label |
JNJ-2113
|